The concentration of cell-free DNA in focal epilepsy

Epilepsy Research

Volumn 105, Issue 3, 2013, Pages 292-298

  Liimatainen, Suvi P ^a   Jylhävä, Juulia ^b   Raitanen, Jani ^b,c   Peltola, Jukka T ^a   Hurme, Mikko A ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

Author keywords

Cell free DNA; Etiology; Focal Epilepsy; Inflammation; Neurodegeneration

Indexed keywords

DNA;

ARTICLE; BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ELECTROENCEPHALOGRAPHY; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEUROIMAGING; NEUROPATHOLOGY; PRIORITY JOURNAL;

AED; ANTIEPILEPTIC DRUG; CD; CELIAC DISEASE; CELL-FREE DNA; CENTRAL NERVOUS SYSTEM; CF-DNA; CNS; ETIOLOGY; EXTRA-TEMPORAL LOBE EPILEPSY; FLE; FOCAL EPILEPSY; FRONTAL LOBE EPILEPSY; HIPPOCAMPAL SCLEROSIS; HS; IL; IL1-RA; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMATION; INOS; INTERLEUKIN; INTERLEUKIN 1 RECEPTOR ANTAGONIST; MAGNETIC RESONANCE IMAGING; MRI; NEURODEGENERATION; NEURON-SPECIFIC ENOLASE; NSE; OCCIPITAL LOBE EPILEPSY; OLE; PARIETAL LOBE EPILEPSY; PLE; S-100B; S-100B PROTEIN; SD; STANDARD DEVIATION; TBI; TEMPORAL LOBE EPILEPSY; TLE; TNF-Α; TRAUMATIC BRAIN INJURY; TUMOR NECROSIS FACTOR-Α; UDP-GLUCURONOSYLTRANSFERASE 1; UGT1A1; XTLE;

AUTOIMMUNE DISEASES; COHORT STUDIES; DNA; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84880036508     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2013.03.005     Document Type: Article

References (39)

1. Alapirtti T., Rinta S., Hulkkonen J., Mäkinen R., Keränen T., Peltola J. Interleukin-6, interleukin-1 receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J. Neurol. Sci. 2009, 280:94-97.
2. Bengzon J., Mohapel P., Ekdahl C.T., Lindvall O. Neuronal apoptosis after brief and prolonged seizures. Prog. Brain Res. 2002, 135:111-119.
3. Bernasconi A., Tasch E., Cendes F., et al. Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog. Brain Res. 2002, 135:297-304.
4. Callenbach P.M., Jol-Van Der Zijde C.M., Geerts A.T., et al. Immunoglobulins in children with epilepsy: the dutch study of epilepsy in childhood. Clin. Exp. Immunol. 2003, 132:144-151.
5. Campello Yurgel V., Ikuta N., Brondani da Rocha A., et al. Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males. J. Neurotrauma 2007, 24:1172-1181.
6. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
7. De Simoni M.G., Perego C., Ravizza T., et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12:2623-2633.
8. Eriksson K., Peltola J., Keränen T., Haapala A.M., Koivikko M.M. High prevalence of antiphospholipid antibodies in children; a controlled study of 50 patients. Epilepsy Res. 2001, 46:129-137.
9. Gahan P.B., Anker P., Stroun M. Metabolic DNA as the origin of spontaneously released DNA?. Ann. N.Y. Acad. Sci. 2008, 1137:7-17.
10. Jylhävä J., Lyytikäinen L.P., Kähönen M., et al. A genome-wide association study identifies UGT1A1 as a regulator of serum cell-free DNA in young adults: the cardiovascular risk in young finns study. PLoS ONE 2012, 7:e35426.
11. Kälviäinen R., Salmenperä T. Do recurrent seizures cause neuronal damage?. A series of studies with MRI volumetry in adults with partial epilepsy. Prog. Brain Res. 2002, 135:279-295.
12. Kälviäinen R., Salmenperä T., Partanen K., et al. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998, 50:1377-1382.
13. Kotloski R., Lynch M., Lauersdorf S., et al. Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog. Brain Res. 2002, 135:95-110.
14. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 2010, 51:1069-1077.
15. Lam N.Y.-L., Rainer T.H., Wong L.K.-S., Lam W.Y.-M.D., Lo Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24h of symptom onset. Resuscitation 2006, 68:71-78.
16. Lehtimäki K.A., Peltola J., Koskikallio E., Keränen T., Honkaniemi J. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Mol. Brain Res. 2003, 110:253-260.
17. Lehtimäki K.A., Keränen T., Huhtala H., et al. Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J. Neuroimmunol. 2004, 152:121-125.
18. Liimatainen S.P., Raitanen J.A., Ylinen A.M., Peltola M.A., Peltola J.T. The benefit of active drug trials is dependent on aetiology in refractory focal epilepsy. J. Neurol. Neurosurg. Psychiatry 2008, 79:808-812.
19. Liimatainen S., Fallah M., Kharazmi E., Peltola M., Peltola J. Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J. Neurol. 2009, 256:796-802.
20. Liimatainen S., Lehtimäki K., Raitala A., et al. Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy. Epilepsy Res. 2011 Mar 3, (Epub ahead of print).
21. Mittra I., Nair N.K., Mishra P.K. Nucleic acids in circulation: are they harmful to the host?. J. Biosci. 2012, 37:301-312.
22. Palmio J., Peltola J., Vuorinen P., Laine S., Suhonen J., Keränen T. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent noncomplicated tonic-clonic seizures. J. Neurol. Sci. 2001, 183:27-31.
23. Palmio J., Keränen T., Alapirtti T., et al. Elevated serum neuron-specific enolase in patients with temporal lobe epilepsy: a video-EEG study. Epilepsy Res. 2008, 81:155-160.
24. Peltola J.T., Haapala A.M., Isojärvi J.J., et al. Antiphosholipid and antinuclear antibodies in epileptic syndromes and newly onset seizure disorders. Am. J. Med. 2000, 109:712-717.
25. Peters D.L., Pretorius P.J. Origin, translocation and destination of extracellular occurring DNA - a new paradigm in genetic behaviour. Clin. Chim. Acta 2011, 12:806-811.
26. Pitkänen A., Nissinen J., Nairismägi J., et al. Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog. Brain Res. 2002, 135:67-83.
27. Ravizza T., Boer K., Redeker S., et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol. Dis. 2006, 24:128-143.
28. Rhodes A., Wort S.J., Thomas H., et al. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit. Care 2006, 10:R60.
29. Scalzo P.L., Ikuta N., Cardoso F., et al. Quantitative plasma DNA analysis in Parkinson's disease. Neurosci. Lett. 2009, 452:5-7.
30. Semah F., Picot M.C., Adam C., et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology 1998, 51:1256-1262.
31. Stephen L.J., Kwan P., Brodie M.J. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?. Epilepsia 2001, 42:357-362.
32. Sutula T., Pitkänen A. Summary: mechanisms of seizure-induced damage. Prog. Brain Res. 2002, 135:211-212.
33. Swarup V., Srivastava A.K., Padma M.V., Rajeswari M.R. Quantification of circulating plasma DNA in Friedreich's ataxia and spinocerebellar ataxia types 2 and 12. DNA Cell Biol. 2011, 30:389-394.
34. Tong Y.K., Lo Y.M. Diagnostic developments involving cell-free (circulating) nucleic acids. Clin. Chim. Acta 2006, 363:187-196.
35. Tsai N.W., Lin T.K., Chen S.D., et al. The value of serial plasma nuclear and mitochondrial DNA levels in patients with acute ischemic stroke. Clin. Chim. Acta 2011, 412:476-479.
36. Tsang J.C., Lo Y.M. Circulating nucleid acids in plasma/serum. Pathology 2007, 39:197-207.
37. Vezzani A., Moneta D., Conti M., et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:11534-11539.
38. Vezzani A., Peltola J., Janigro D. Inflammation. Epilepsy: A Comprehensive Textbook 2007, 267-276. Lippincott, Williams & Wilkins, Philadelphia. J. Engel, T.A. Pedley (Eds.).
39. Wijeratne S., Butt A., Burns S., et al. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann. N.Y. Acad. Sci. 2004, 1022:232-238.